{
    "code": 0,
    "data": [
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2025",
            "news_body": "The Board of Directors of the Company in their Meeting held on February 11 2026 has inter-alia considered and approved the Un-Audited Financial Results of the Company along with the Limited Review Report for the Quarter and Nine Months ended on December 31 2025.",
            "news_id": "5b0a9fef-94b3-40cf-b93e-bafadb8ce985",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df9e3cc9-3a03-4f4a-85c0-06eb4c1250b3.pdf",
            "news_date": "2026-02-11 17:44:31",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2025",
            "news_body": "The Board of Directors of the Company in their Meeting held on February 11 2026 has inter-alia considered and approved the Un-Audited Financial Results of the Company along with the Limited Review Report for the Quarter and Nine Months ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df9e3cc9-3a03-4f4a-85c0-06eb4c1250b3.pdf",
            "news_date": "2026-02-11 17:44:31"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome For The Board Meeting Held On 11/02/2026",
            "news_body": "The Board of Directors of the Company in the Meeting held on February 11 2026 has inter-alia considered and approved the Unaudited Financial Results of the Company along with the Limited Review Report issued by the Statutory Auditors for the Quarter and Nine-Months ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=161123a6-3901-4a28-9f9a-194a42a07872.pdf",
            "news_date": "2026-02-11 17:36:07"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Meeting Scheduled On February 11 2026",
            "news_body": "Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve the Un-Audited Financial Results for the Quarter ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b096e4cb-6741-40e5-9891-9f03c4ef1c5b.pdf",
            "news_date": "2026-02-05 15:11:52"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "We hereby inform you that the Outlook of the Credit Ratings assigned to the Bank loan facilites of the Company has been revised by ICRA Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24e26812-9981-4046-91bd-d447997ffdcd.pdf",
            "news_date": "2026-01-23 19:02:42"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the Quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8899683d-646d-46dc-a80d-76cf5ccd603f.pdf",
            "news_date": "2026-01-09 15:21:41"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for Closure of Trading Window.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba313bae-a1e8-40c1-823a-99c09b292ec6.pdf",
            "news_date": "2025-12-26 12:28:12"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby enclose the Newspaper publication of the extract of the Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30 2025 as published in \"Business Standard\" and \"Makkal Kural\" on November 13 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26368477-67e1-439e-9faa-37bbc9cb64b2.pdf",
            "news_date": "2025-11-14 17:16:40"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "The Board of Directors of the Company in the Meeting held on November 11 2025 has inter-alia considered and approved the Unaudited Financial Results of the Company along with the Limited Review Report issued by the Statutory Auditors for the Quarter and Half Year ended September 30 2025.",
            "news_id": "72715064-0568-4194-9b1e-35ca75b4ecd7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6eac122d-dc0b-4cfd-b2e8-18656852940b.pdf",
            "news_date": "2025-11-11 17:32:47",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "The Board of Directors of the Company in the Meeting held on November 11 2025 has inter-alia considered and approved the Unaudited Financial Results of the Company along with the Limited Review Report issued by the Statutory Auditors for the Quarter and Half Year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6eac122d-dc0b-4cfd-b2e8-18656852940b.pdf",
            "news_date": "2025-11-11 17:32:47"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome For The Board Meeting Held On 11/11/2025",
            "news_body": "The Board of Directors of the Compant in the meeting held on November 11 2025 has inter-alia considered and approved the Unaudited Financial Results of the Company along with the Limited Review Report issued by the Statutory Auditors of the Company for the Quarter and Half Year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4074249-ecdb-4427-b1a7-e5d87788d523.pdf",
            "news_date": "2025-11-11 17:22:28"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Meeting Scheduled On November 11 2025",
            "news_body": "Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve the Un-Audited Financial Results for the Quarter and Half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b25ab06f-0831-4746-aa18-4d09054109b5.pdf",
            "news_date": "2025-11-06 11:43:02"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the Quarter ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a302936b-c05f-4fdd-a727-c8e3a8f7c0b9.pdf",
            "news_date": "2025-10-10 12:17:58"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47be40dd-a172-46a7-bd39-cabd8702822b.pdf",
            "news_date": "2025-09-26 15:06:14"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "We hereby inform that the Members at the 30th Annual General Meeting of the Company held on September 19 2025 had inter-alia approved (i) Appointment of Mr. Navin Kumar as Independent Director of the Company and (ii) Re-appointment of Mr. Palamadai Krishnan Sundaresan and Mrs. Ravichandran Chitra as Independent Directors of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dae18ff7-7c39-44ce-a221-eede3e0b6b71.pdf",
            "news_date": "2025-09-19 18:38:03"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "We hereby inform that the Members at the 30th Annual General Meeting of the Company held on September 19 2025 had inter-alia approved (i) Appointment of Mr. Navin Kumar as Independent Director of the Company and (ii) Re-appointment of Mr. Palamadai Krishnan Sundaresan and Mrs. Ravichandran Chitra as Independent Directors of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ba0858e-abf6-4715-bf35-8375812039c2.pdf",
            "news_date": "2025-09-19 18:33:07"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "We herewith enclose the Outcome / Proceedings of the 30th Annual General Meeting of the Company held on September 19 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e683cfb-581c-4577-82ad-0f5b0c7e2f60.pdf",
            "news_date": "2025-09-19 15:56:51"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We herewith enclose the Newspaper Publication in connection with 30th Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=789ccd13-5f12-4a98-81e7-f711ff27ec32.pdf",
            "news_date": "2025-08-28 16:27:24"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 30Th Annual General Meeting Of The Company For The F.Y 2024-2025",
            "news_body": "We herewith enclose the Notice of 30th Annual General Meeting of the Company scheduled to be held on Friday September 19 2025 at 10.00 A.M for the FY 2024-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da93437c-f0ec-4df1-aa95-0848d1b23bb6.pdf",
            "news_date": "2025-08-26 18:02:52"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "We herewith enclose the Annual Report of the Company for the F.Y 2024-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48758623-f900-4e76-aaf3-6abdd286e369.pdf",
            "news_date": "2025-08-26 17:56:54"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Intimation",
            "descriptor": "Book Closure",
            "caption": "Book Closure For 30Th Annual General Meeting (AGM)",
            "news_body": "Intimation for Book Closure for the purpose of 30th Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=634e81bc-198a-453e-8b3a-be45141cec03.pdf",
            "news_date": "2025-08-21 17:05:14"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting - 30Th AGM On September 19 2025",
            "news_body": "We hereby inform that the 30th Annual General Meeting of the Company (AGM) is scheduled to be held on Friday September 19 2025 at 10.00 A.M through Video Conferencing (VC) / Other Audio Visual Means (OAVM).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0ce98a3-f7a1-409e-9131-5bb13baab18c.pdf",
            "news_date": "2025-08-21 16:57:36"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby enclose the Newspaper Publication of the Extract of the Unaudited Financial Results of the Company for the Quarter ende June 30 2025 in \"Business Standard\" and \"Makkal Kural\" on August 14 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ff5bc63-b692-4b73-9fcd-139e338b8d01.pdf",
            "news_date": "2025-08-14 17:38:10"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "We hereby inform that the Board of Directors at its Meeting held on 12/08/2025 has approved the re-appointment of Mrs. Ravichandran Chitra (DIN: 07749125) and Mr. Palamadai Krishnan Sundaresan (DIN: 06954189) as Non-Executive Independent Directors of the Company for a Second Term of Five consecutive years subject to approval of Shareholders at the ensuing Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a87c65d9-b8e3-4278-916f-a64129976e18.pdf",
            "news_date": "2025-08-12 18:14:08"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "We hereby inform that the Board of Directors at its meeting held on 12/08/2025 has approved the Re-appointment of Mrs. Ravichandran Chitra (DIN: 07749125) and Mrs. Palamadai Krishnan Sundaresan (DIN: 06954189) as Non-Executive Independent Directors of the Company for a second term of Five consecutive years subject to apporval of Shareholders at the ensuing Annual General Meeting and Re-appointment of Mr. Bafna Mahaveer Chand as Chief Executive Officer of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae1ec3d9-c791-478e-9417-2020ccc6ce56.pdf",
            "news_date": "2025-08-12 17:51:10"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Unaudited Financial Results for the Quarter Ended June 30 2025.",
            "news_id": "bad5ebbc-863d-4711-be0a-3c2eae2c5ea5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94ab99b2-5474-4253-9183-8e8712089137.pdf",
            "news_date": "2025-08-12 16:52:57",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Unaudited Financial Results for the Quarter Ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94ab99b2-5474-4253-9183-8e8712089137.pdf",
            "news_date": "2025-08-12 16:52:57"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome For The Board Meeting Held On 12/08/2025",
            "news_body": "The Board of Directors in the meeting held on 12/08/2025 has inter-alia approved i) Unaudited Financial Results of the Company for the Quarter ended June 30 2025 along with the Limited Review Report; ii) Fixed the date of Annual General Meeting (AGM) Book Closure Date and Cut-Off Date for the purpose of AGM; and iii) Reconstitution of Nomination & Remuneration Committee of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=895f9b00-3506-4261-bc95-2183273a6991.pdf",
            "news_date": "2025-08-12 16:40:14"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Meeting Scheduled On August 12 2025",
            "news_body": "Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve the Un-Audited Financial Results for the Quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9140ea36-062c-4dfc-ab20-d6aa60369f5c.pdf",
            "news_date": "2025-08-07 15:04:09"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the Quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f00cbc3-a115-4b40-8c2f-069a108eebe6.pdf",
            "news_date": "2025-07-05 13:50:23"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015",
            "news_body": "Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 for Sale / Disposal of Manufacturing Unit of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca591aea-5d3b-42d1-946a-5b15a7f8f9c7.pdf",
            "news_date": "2025-06-30 18:18:18"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b47f5e60-7f00-4d66-8c18-ec4d61370e17.pdf",
            "news_date": "2025-06-26 15:53:55"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Re-Constitution Of Committees",
            "news_body": "We hereby inform that the Board of Directors of the Company has re-constituted the Audit Committee Nomination-Remuneration Committee of the Board w.e.f June 25 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=286ce4cd-e77b-491d-9b75-4ec70bcf7c3f.pdf",
            "news_date": "2025-06-24 16:23:24"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Intimation for retirement of Mr. Palamadai Krishnan Sundaresan (DIN: 06954189) as an Independent Director of the Company upon completion of his first term with effect from June 24 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df1d386e-f927-456c-9242-c17ddf020f7d.pdf",
            "news_date": "2025-06-24 16:16:42"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Retirement",
            "caption": "Announcement under Regulation 30 (LODR)-Retirement",
            "news_body": "Intimation for retirement of Mr. Palamadai Krishnan Sundaresan (DIN: 06954189) as an Independent Director of the Company upon completion of his first term with effect from June 24 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=957bb591-1653-4245-9421-f6cf2f7bc32e.pdf",
            "news_date": "2025-06-24 16:13:15"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Intimation for appointment of Mr. Navin Kumar (DIN: 08778662) as an Additional Director (Non-Executive Independent Director) of the Company with effect from June 23 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9079e6c4-bbae-4a77-9af3-a6082cce4ba4.pdf",
            "news_date": "2025-06-23 15:34:14"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Intimation for appointment of Mr. Navin Kumar (DIN: 08778662) as an Additional Director (Non-Executive Independent Director) of the Company with effect from June 23 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=295dfb79-b0c9-4bcd-b719-74faae864e34.pdf",
            "news_date": "2025-06-23 15:28:19"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby enclose the Newspaper Publication for the Audited Financial Results of the Company for the Quarter & Year ended March 31 2025 published in \"Business Standard\" and \"Makkal Kural\" on May 28 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29b987cc-17eb-4457-a7ae-12623798d8d4.pdf",
            "news_date": "2025-05-30 12:14:01"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial Compliance Report for the year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=426ab054-9bfd-4b57-a604-c245de92004c.pdf",
            "news_date": "2025-05-29 18:25:37"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter & Year Ended March 31 2025",
            "news_body": "Audited Financial Results of the Company for the Quarter & Year ended March 31 2025.",
            "news_id": "21904763-5fa3-4635-86cb-c3779eeff876",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c83770de-43dd-45d0-8284-76f7a45e2481.pdf",
            "news_date": "2025-05-26 17:39:23",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results For The Quarter & Year Ended March 31 2025",
            "news_body": "Audited Financial Results of the Company for the Quarter & Year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c83770de-43dd-45d0-8284-76f7a45e2481.pdf",
            "news_date": "2025-05-26 17:39:23"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome For The Board Meeting Held On 26/05/2025",
            "news_body": "The Board of Directors of the Company in the Meeting held on May 26 2025 has inter-alia considered and approved the Audited Financial Results of the Company along with the Auditors Report issued by the Statutory Auditors of the Company for the Quarter and Year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6297be33-e872-4b24-85a7-441965c4a97e.pdf",
            "news_date": "2025-05-26 17:27:40"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Re-Constitution Of Nomination & Remuneration Committee.",
            "news_body": "We hereby inform that the Board of Directors of the Company has re-constituted the Nomination & Remuneration Committee of the Board w.e.f May 20 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cc853aa-f0b9-4df3-b1fb-abe61a1525c4.pdf",
            "news_date": "2025-05-20 16:55:35"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Scheduled On May 26 2025",
            "news_body": "Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve the Audited Financial Results for the Quarter & Year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb472921-2d99-4c6b-9d19-0b721ac5ec6d.pdf",
            "news_date": "2025-05-19 16:59:07"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Reg 30 Of SEBI (LODR) Regulations 2015 - Award",
            "news_body": "We are glad to announce that the Company has been honoured with the Emerging Company of the Year in Healthcare by the MSME Chamber of Commerce and Industry India.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2e1b86a-38e0-4685-81da-14c7a1ded14b.pdf",
            "news_date": "2025-04-29 16:43:09"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation74(5) of SEBI (DP) Regulations 2018 for Quarter ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c638d587-7cb6-48f6-9ebc-4388abdf63ac.pdf",
            "news_date": "2025-04-08 13:19:52"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Intimation for resignation of Mr. Krishna Yeachuri as an Independent Director of the Company with effect from closure of business hours on March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de735d42-95a2-4e59-aba9-11f9a341fe27.pdf",
            "news_date": "2025-04-01 17:10:25"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Director",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
            "news_body": "We hereby inform that Mr. Krishna Yeachuri has tendered his resignation as an Independent Director of the Company with effect from close of business hours on March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c6afd87-d819-4926-b804-8d095880b4ba.pdf",
            "news_date": "2025-04-01 17:04:30"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for SRJR Lifesciences LLP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=201DBF18_6C4D_4B32_8A26_9B119520E37F_114552.pdf",
            "news_date": "2025-04-01 11:45:58"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for SRJR Lifesciences LLP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8DE0D912_B2AB_4505_B4CE_8EA9F668BBC5_102422.pdf",
            "news_date": "2025-04-01 10:24:27"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 7(2) Of SEBI (PIT) Regulations 2015",
            "news_body": "We hereby enclose the Disclosure under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations 2015 received from M/s. SRJR Lifesciences LLP regarding the Sale of Shares of the Company pursuant to Offer for Sale (OFS) through Stock Exchange Mechanism. This submission is made pursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be8d63bb-135a-4d7b-ae54-a31e30c022ab.pdf",
            "news_date": "2025-03-31 13:29:34"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General",
            "descriptor": "Sale of shares",
            "caption": "Notice of Offer for Sale of Shares by Promoter & Flooor Price",
            "news_body": "SRJR Lifesciences LLP (the \"Seller\") proposes to sell up to 3145296 Equity Shares the Company (representing 13.30% of the total issued and paid-up Equity Share Capital of the Company) (\"Offer Shares\") on Thursday March 27 2025 (\"T day\") {for Non-Retail Investors (as defined below) only} and on Friday March 28 2025 (\"T+1 day\") {for Retail Investors (as defined below) and for Non-Retail Investors who choose to carry forward their un-allotted bids from T day}) through a separate designated window of BSE Limited (the \"BSE\") and the National Stock Exchange of India Limited (the \"NSE\" and together with BSE the \"Stock Exchanges\").<BR><BR>Date and time of the opening and closing of the Offer :<BR><BR>The Offer shall take place on a separate window of the Stock Exchanges on Thursday March 27 2025 and Friday March 28 2025 commencing at 9:15 a.m. (Indian Standard Time) and shall close at 3:30 p.m. (Indian Standard Time) on both days in accordance with the details given below:<BR><BR>For Non-Retail Investors (as defined below): Thursday March 27 2025 (\"T day\")<BR><BR>Only Non-Retail Investors shall be allowed to place their bids on T day i.e. Thursday March 27 2025. While placing their bids Non-Retail Investors may indicate their willingness to carry forward their un-allotted bids to T+1 day for allocation to them in the unsubscribed portion of Retail Category (defined below).<BR><BR>The Offer shall take place during trading hours on a separate window of the Stock Exchanges on T day i.e. Thursday March 27 2025 commencing at 9:15 a.m. and shall close at 3:30 p.m. Indian Standard Time on the same date.<BR><BR>For Retail Investors (as defined below) and Non- Retail Investors who chose to carry forward their un-allotted bids: Friday March 28 2025 (\"T+1 day\")<BR><BR>The Offer shall continue to take place during trading hours on a separate designated window of the Stock Exchanges on T+1 day i.e. Friday March 28 2025 commencing at 09:15 a.m. (Indian Standard Time) and shall close at 03:30 p.m. (Indian Standard Time) on the same date.<BR><BR>Only Retail Investors (defined below) shall be allowed to place their bids on T+1 day i.e. Friday March 28 2025. Further those Non-Retail Investors who have placed their bids on T day and have chosen to carry forward their un-allotted bids to T+1 day shall be allowed to carry forward their un-allotted bids for allocation to them in the unsubscribed portion of Retail Category (defined below) and also revise their bids on T+1 day as per the OFS Guidelines.<BR><BR>(T day and T+1 day together referred to as \"Trade Dates\")<BR><BR>Offer Price : The offer price for the Offer shall be Rs. 72 (Rupees Seventy-Two Only) per Equity Share (\"Offer Price\"). The offer is at Single clearing price.<BR><BR>No discount is being offered to the Retail Investors.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9DED72B4-E07A-4AC3-8A4E-5CE0337EC281-185241.pdf",
            "news_date": "2025-03-26 18:52:47"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2becb08-ce92-4cf2-8b57-3ad5c478ca1d.pdf",
            "news_date": "2025-03-26 15:23:25"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby enclose the Newspaper Publication for the Unaudited Financial Results of the Company for the Quarter and Nine Months ended December 31 2024 published in \"Business Standard\" and \"Makkal Kural\" on February 08 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc138372-54b9-4929-9fc0-d222c438ae16.pdf",
            "news_date": "2025-02-11 13:05:45"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated Filing (Financial) for the Quarter and Nine Months ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7176f13-d379-4231-8553-1d1478c856d5.pdf",
            "news_date": "2025-02-06 17:30:28"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended 31/12/2024",
            "news_body": "Unaudited Financial Results for the Quarter and Nine Months ended 31/12/2024",
            "news_id": "2145c147-0e2d-4ddd-bb5a-a61f4bb91d2f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9a908db-934c-4781-9fc3-db76362112d9.pdf",
            "news_date": "2025-02-06 17:02:08",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended 31/12/2024",
            "news_body": "Unaudited Financial Results for the Quarter and Nine Months ended 31/12/2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9a908db-934c-4781-9fc3-db76362112d9.pdf",
            "news_date": "2025-02-06 17:02:08"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Board Meeting Held On 06/02/2025",
            "news_body": "The Board of Directors in the meeting held on February 06 2025 has inter-alia approved Unaudited Financial Results of the Company for the Quarter and Nine Months ended December 312024 along with the Limited Review Report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88345c0b-2377-40ed-a18f-0d165e6fc52b.pdf",
            "news_date": "2025-02-06 16:56:39"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Scheduled On February 06 2025",
            "news_body": "BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 inter alia to consider and approve the Unaudited Financial Results for the Third Quarter ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93f99a59-f321-4cc0-bef0-e0c2e79c4616.pdf",
            "news_date": "2025-01-28 16:39:36"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the Quarter ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b90eb29-285d-4bdd-87e5-e263c6813a3a.pdf",
            "news_date": "2025-01-09 16:43:50"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby enclose the Newspaper Publication for the Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30, 2024 published in Business Standard and Makkal Kural on 13-11-2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=568c6c36-bd1f-45c8-a7ce-c9ff6e990f76.pdf",
            "news_date": "2024-11-16 15:16:48"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30.09.2024",
            "news_body": "Unaudited Financial Results for the Quarter ended 30.09.2024",
            "news_id": "3f53c6af-4d9f-498f-9112-78de1db298ae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc8c8c54-7062-45a3-a7de-09516e8012d1.pdf",
            "news_date": "2024-11-11 17:07:50",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30.09.2024",
            "news_body": "Unaudited Financial Results for the Quarter ended 30.09.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc8c8c54-7062-45a3-a7de-09516e8012d1.pdf",
            "news_date": "2024-11-11 17:07:50"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 11/11/2024",
            "news_body": "The Board of Directors in the meeting held on 11/11/2024 has inter-alia approved Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30,2024 along with the Limited Review Report",
            "news_id": "69db40c5-e018-4a5c-9884-6774c5050655",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb15c923-90fa-49eb-a515-bb695b49351b.pdf",
            "news_date": "2024-11-11 17:02:24",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 11/11/2024",
            "news_body": "The Board of Directors in the meeting held on 11/11/2024 has inter-alia approved Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30,2024 along with the Limited Review Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb15c923-90fa-49eb-a515-bb695b49351b.pdf",
            "news_date": "2024-11-11 17:02:24"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Update on board meeting",
            "news_body": "The Board Meeting to be held on 11/11/2024 has been revised to 11/11/2024 BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 ,inter alia, to consider and approve the Unaudited Financial Results for the Second Quarter ended September 30, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52212661-296f-4a74-93c2-4cb54c27d4d3.pdf",
            "news_date": "2024-11-04 12:50:12"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Scheduled On November 11, 2024",
            "news_body": "BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 ,inter alia, to consider and approve the Unaudited Financial Results for the Second Quarter ended September 30, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99be41aa-28a5-44b2-bbc5-91b50d0eb2c6.pdf",
            "news_date": "2024-11-04 12:34:40"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for quarter ended September 30, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce1c6085-a414-4a84-917d-bdbc6b678b93.pdf",
            "news_date": "2024-10-10 17:04:44"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for Closure of Trading Window.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=783c8ff5-86dd-4125-ad11-977566fcabe1.pdf",
            "news_date": "2024-09-28 10:23:41"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizer''s Report",
            "news_body": "We herewith enclose the Voting Results of the 29th Annual General Meeting of the Company along with the Consolidated Scrutinizers Report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03937cfb-ec5d-4c18-b87b-e927f48b1f40.pdf",
            "news_date": "2024-09-26 14:20:45"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "We hereby inform that the Shareholders in the 29th Annual General Meeting held on September 25, 2024 inter-alia approved the re-appointment of Ms. Shanmugam Hemalatha (DIN: 02714329) as Whole-Time Director of the Company, for a period of 5 years.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2db193ee-1796-4d5a-a041-2b1c6bc05795.pdf",
            "news_date": "2024-09-25 17:38:12"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Outcome / Proceedings of the 29th Annual General Meeting of the Company held on September 25, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd80b032-ffee-467a-a0e1-287d64bd82fa.pdf",
            "news_date": "2024-09-25 15:12:24"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Announcement Under Reg 30 Of SEBI (LODR) Regulations, 2015 - Award",
            "news_body": "We are glad to announce that the Company has been awarded All-Round Silver Star - Export Performance Award by Pharmaceuticals Export Promotion Council of India.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b204c0d-111c-4905-9f20-001d7ac4dd9e.pdf",
            "news_date": "2024-09-09 18:03:04"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We herewith enclose the copy of Newspaper publication published in connection with 29th Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a42add9c-8094-4323-ae4e-7a6efae8298e.pdf",
            "news_date": "2024-09-03 17:37:01"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Notice Of 29Th Annual General Meeting Of The Company For The F.Y 2023-2024",
            "news_body": "We herewith enclose the Notice of 29th Annual General Meeting of the Company to be held for the F.Y 2023-2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=057cddb6-26c7-48c4-b3a3-e247d8511031.pdf",
            "news_date": "2024-09-02 20:20:28"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "We herewith enclose the Annual Report of the Company for the F.Y 2023-2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=171bcaf8-6799-49a7-bbee-e844191fdadf.pdf",
            "news_date": "2024-09-02 20:16:09"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Corp. Action",
            "descriptor": "Book Closure",
            "caption": "Book Closure For 29Th Annual General Meeting (AGM)",
            "news_body": "Intimation for Book Closure for the purpose of 29th Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a869d33-9663-4dfd-a617-c0d4ececc75a.pdf",
            "news_date": "2024-08-30 15:33:50"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting - 29Th AGM On September 25, 2024",
            "news_body": "We hereby inform that the 29th Annual General Meeting (AGM) will be held on Wednesday, the September 25, 2024 at 10.30 A.M (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f26f082d-7855-46cc-b3ca-79c6d0224a29.pdf",
            "news_date": "2024-08-30 15:25:03"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby enclose the Newspaper Publication for the Unaudited Financial Results for the Quarter ended June 30, 2024 published in Business Standard (English) and Makkal Kural (Tamil) on August 15, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f1b4cf1-2360-488c-be67-ce54d71626f4.pdf",
            "news_date": "2024-08-16 11:49:41"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015",
            "news_body": "Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 for Sale / Disposal of Manufacturing Unit of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4eb3c6de-2b2b-4138-8061-20595a035cad.pdf",
            "news_date": "2024-08-13 20:37:37"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 13/08/2024",
            "news_body": "The Board of Directors in the meeting held on 13/08/2024 has inter-alia approved i) Unaudited Financial Results of the Company for the Quarter ended June 30,2024 along with the Limited Review Report; ii) Fixed the date of Annual General Meeting (AGM), Book Closure Date and Cut-Off Date for the purpose of AGM.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=628c0deb-c59f-40db-a958-191ee60766b4.pdf",
            "news_date": "2024-08-13 16:05:49"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30.06.2024",
            "news_body": "Unaudited Financial Results for the Quarter ended 30.06.2024",
            "news_id": "87a3b7c6-e1f8-4817-ba5b-ecb3e4e01933",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26c45804-7d01-4e2d-9909-a2593c7c9f73.pdf",
            "news_date": "2024-08-13 15:58:43",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30.06.2024",
            "news_body": "Unaudited Financial Results for the Quarter ended 30.06.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26c45804-7d01-4e2d-9909-a2593c7c9f73.pdf",
            "news_date": "2024-08-13 15:58:43"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The First Quarter Ended June 30, 2024.",
            "news_body": "BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve the Unaudited Financial Results for the First Quarter ended June 30, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79dd0833-7a04-4f58-95a1-e26583686a31.pdf",
            "news_date": "2024-08-06 17:58:15"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for quarter ended June 30, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73f56dc3-0938-46a9-a5e3-d9bbee5d45c7.pdf",
            "news_date": "2024-07-11 14:38:13"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (LODR) Regulations For Temporary Disruption Of Operations.",
            "news_body": "Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 for Temporary Disruption of operations at Manufacturing facility situated at Grantlyon, Chennai.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17a0d835-915e-4ec8-abca-600010fcda2c.pdf",
            "news_date": "2024-06-29 14:18:16"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for Closure of Trading Window.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08b5fb67-1f7d-4f03-8a90-302745e331c2.pdf",
            "news_date": "2024-06-25 17:15:51"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby enclose the Newspaper Publication for the Audited Financial Results for the Quarter ended March 31, 2024 published in Business Standard (English) and Makkal Kural (Tamil) on May 31, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44aa7525-1d92-4f47-b354-defbd6ee9491.pdf",
            "news_date": "2024-05-31 17:51:58"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "We are herewith filing the Annual Secretarial Compliance Report for the financial year ended March 31, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcf9a1d8-a888-43fe-93bc-9f3c3754bfe7.pdf",
            "news_date": "2024-05-30 19:13:15"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "We hereby inform that the Board of Directors in their meeting held on May 29, 2024 has appointed Mr. A Mohanachandran as the Company Secretary & Compliance officer of the Company w.e.f May 29, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a12d3fcd-95a7-409a-9a81-d93f0ba79421.pdf",
            "news_date": "2024-05-29 19:26:58"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 29/05/2024.",
            "news_body": "The Board of Directors in the meeting held on 29/05/2019 has inter-alia (i) approved the audited financial results of the Company for the quarter & year ended March 31, 2024; (ii) ii). Appointment of Mr. A. Mohanachandran, as the Company Secretary & Compliance Officer of the Company with effect from May 29, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea0ed213-6a36-4392-8747-e557d90bee2d.pdf",
            "news_date": "2024-05-29 19:08:56"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results Of The Company For The Quarter & Year Ended 31/03/2024",
            "news_body": "We are herewith submitting the Audited Financial Results for the Quarter & Year ended 31/03/2024",
            "news_id": "df070be2-14d5-4f59-9901-8bd2bb42d937",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=033fb19e-35d8-4008-bec4-9fb14906be2e.pdf",
            "news_date": "2024-05-29 19:05:31",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results Of The Company For The Quarter & Year Ended 31/03/2024",
            "news_body": "We are herewith submitting the Audited Financial Results for the Quarter & Year ended 31/03/2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=033fb19e-35d8-4008-bec4-9fb14906be2e.pdf",
            "news_date": "2024-05-29 19:05:31"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2024",
            "news_body": "BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve Consideration and Approval of the Audited Financial Results of the Company for the Quarter and Year ended March 31, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f97c262-971d-41c3-a680-21af8f1188c4.pdf",
            "news_date": "2024-05-22 18:50:05"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Announcement Regarding Inauguration Of New Quality Control Laboratory Of Company",
            "news_body": "We are delighted to announce the inauguration of new State-of-the-Art Quality Control Laboratory of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0b09ad1-a5de-465b-923e-92282809d054.pdf",
            "news_date": "2024-04-26 17:24:51"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Reg. 7(3) \u2013 Compliance Certificate (RTA & Compliance Officer)",
            "caption": "Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Period Ended 31St March, 2024",
            "news_body": "We are herewith submitting the Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the period ended 31st March, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe72aceb-8a7d-4564-ab52-33680989f651.pdf",
            "news_date": "2024-04-24 17:51:40"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Resignation of Company Secretary / Compliance Officer",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
            "news_body": "We hereby inform that Mr. Vishnu Vasudeva Kuppa has resigned from the position of Company Secretary & Compliance officer of the Company with effect from 23rd April, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f31b0bb9-aee7-42e9-a700-c7f9a9c19462.pdf",
            "news_date": "2024-04-23 18:43:04"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Reg. 40 (10) - PCS Certificate for Transfer / Transmission / Transposition",
            "caption": "Compliance Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2024",
            "news_body": "We are herewith enclosing the Compliance Certificate issued under Regulation 40(9) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 for the year ended 31st March, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b62750e9-fd52-4b78-b77f-2779dba561fd.pdf",
            "news_date": "2024-04-22 17:45:25"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "We are herewith enclosing Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for Quarter ended 31st March, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bcb2cee-4667-4e8b-8e3a-8aafc91283e0.pdf",
            "news_date": "2024-04-15 17:55:40"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The Trading Window for the designated persons, connected persons, shall remain closed from Sunday, March 31, 2024, up to 48 hours after the declaration of Financial results of the Company by the Board of directors for the quarter and year ending March 31, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a41c48eb-603e-40c6-acbc-b89eaa61a3f3.pdf",
            "news_date": "2024-03-25 14:40:21"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "we have furnished herewith newspaper clippings of Un-audited Standalone Financial Results of the Company for the quarter and nine months ended December 31, 2023,  which was approved by the Board in its meeting held on February 12, 2024, and published in the newspapers, namely in Makkal Kural (Tamil edition) and Business Standard (English edition) on Tuesday, February 13, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92bc037e-3b01-4651-b99f-931d0b3fcab9.pdf",
            "news_date": "2024-02-14 13:03:51"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone Financial Results For The Quarter Ended December 31, 2023.",
            "news_body": "we wish to inform that at the meeting of the Board of Directors of the Company held today i.e., February 12, 2024, Monday, the results of the quarter ended on December 31, 2023, duly reviewed by Audit Committee, inter-alia has been considered and approved by the Board of Directors of the Company.",
            "news_id": "11534dc6-b18c-4eea-ae6e-4697561d16ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fac9078e-2a9e-49de-b806-a7f5e13340eb.pdf",
            "news_date": "2024-02-12 17:08:43",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Standalone Financial Results For The Quarter Ended December 31, 2023.",
            "news_body": "we wish to inform that at the meeting of the Board of Directors of the Company held today i.e., February 12, 2024, Monday, the results of the quarter ended on December 31, 2023, duly reviewed by Audit Committee, inter-alia has been considered and approved by the Board of Directors of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fac9078e-2a9e-49de-b806-a7f5e13340eb.pdf",
            "news_date": "2024-02-12 17:08:43"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors - Approval Of Q3 FY24 Financial Results.",
            "news_body": "BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 ,inter alia, to consider and approve A meeting of board of directors of the Company is scheduled to be held on Monday, February 12, 2024, inter-alia, to consider and approve the Un-Audited Standalone Financial Results of the Company for the third quarter of FY24 ended December 31, 2023, together with the 'Limited Review Report' for the said period.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64d6ff3f-058a-4554-be41-d3db22b0e5eb.pdf",
            "news_date": "2024-02-02 12:21:56"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Pursuant to Regulation 74(5) of SEBI(DP) Regulations, 2018, we enclosed herewith a certificate dated January 04, 2024, received from M/s Cameo Corporate Services Limited, the Registrar and Share Transfer Agent of the Company, confirming the dematerialization of share certificate within the prescribed timelines, during the quarter ended December 31, 2023.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64201c94-37f0-4727-ade0-4b89e5e59fc0.pdf",
            "news_date": "2024-01-11 14:57:12"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, read with code of conduct for Prohibition of Insider Trading of the Company, the Trading Window for the designed persons, connected persons, and their immediate relatives to deal in the shares of the Company, shall remain closed from Sunday, December 31, 2023, up to 48 hours after declarations of financial results of the Company by the Board for the quarter ending December 31, 2023 (both days inclusive).The date of Board meeting to consider and approve the aforesaid financial results of the Company will be intimated in due course.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f9ff817-f56c-408f-836c-fe3662064a30.pdf",
            "news_date": "2023-12-29 12:15:55"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Filing Of Report Under Regulation 7(2)(B) Securities And Exchange Board Of India(Prohibition Of Insider Trading) Regulations, 2015, As Amended ('SEBI Insider Trading Regulations').",
            "news_body": "Disclosure received under Regulation 7(2)(a) of SEBI (PIT) Regulations, 2015, from SRJR Lifesciences LLP, one of the Promoter of Bafna Pharmaceuticals Limited  (the Company) regarding disposal of equity shares of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84448a26-43db-46e1-94ca-9db5f128cd40.pdf",
            "news_date": "2023-12-25 12:26:42"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Discrepancies In Financial Results.",
            "news_body": "As per BSE e-mail dated December 08, 2023, certified true copy of the resolution passed in the Board of Directors in their meeting held on November 09, 2023, along with the signed financials submitted on the date of Board meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d66e6c2-d7c7-4bdd-aa6c-01561c04358e.pdf",
            "news_date": "2023-12-09 12:45:45"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Strikes /Lockouts / Disturbances",
            "caption": "Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances",
            "news_body": "Commercial productions of the Company has been started from today i.e., Friday, December 08, 2023.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46243395-75d7-49ab-adf4-7f40831a1e7f.pdf",
            "news_date": "2023-12-08 18:36:13"
        },
        {
            "co_code": 28611,
            "bse_code": 532989,
            "isin": "INE878I01022",
            "ann_type": "Company Update",
            "descriptor": "Strikes /Lockouts / Disturbances",
            "caption": "Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances",
            "news_body": "we hereby inform you that due to torrential rains/impact of Michaung cyclone, the Company''s manufacturing facilities in Chennai, Tamil Nadu, was totally flooded/waterlogged around the facilities, and the production activities have been disrupted from December 04, 2023.the Company is assessing the situation and simultaneously undertaking all the requisite actions like draining the water from the facilities, etc., to resume the operations of the facilities.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94d6ae26-db97-43ac-94f5-a39efdd2897b.pdf",
            "news_date": "2023-12-07 13:05:22"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 2023.",
            "news_body": "we wish to inform that at the meeting of the Board of Directors of the Company held on November 09, 2023, the results for the quarter ended September 30, 2023, duly reviewed and recommended by the Audit Committee, inter-alia, has been considered and approved by the Board of Directors of the Company.",
            "news_id": "59524501-e8f1-44a9-8d94-28de4219d024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=231b0c5b-0a73-414b-b100-8b595c2982ca.pdf",
            "news_date": "2023-11-10 15:26:24",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Approval Of Un-Audited Financial Results Of The Company For The II Quarter And Half Year Ended September 30, 2023, For The FY 2023-24.",
            "news_body": "We wish to inform that at the meeting of the Board of Directors of the Company held today i.e., November 09, 2023, Thursday, the results for the quarter and half-year ended on September 30, 2023, duly reviewed and recommended by the Audit Committee, inter-alia, has been considered and approved by the Board of Directors of the Company.<BR> In this regard, we enclose the following:<BR>   <BR>",
            "news_id": "5478bd7b-d14d-4cdc-9575-d19b5a8c7335",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d8543ab-a641-49f2-9e18-71ef2b1c6ec3.pdf",
            "news_date": "2023-11-09 16:56:46",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2023.",
            "news_body": "the Board of Director of Bafna Pharmaceuticals Limited approved the Financial results for the quarter ended June 30, 2023.",
            "news_id": "2ceb2c04-f952-4409-9655-b238f4cdc87f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b6d9276-ea16-4256-8c2e-74d2ec87db7e.pdf",
            "news_date": "2023-08-12 12:09:57",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Year Ended March, 31 2023.",
            "news_body": "We herewith submit the Audited Financial results (standalone) for the quarter and year ended March 31, 2023, which was approved by the Board Of Directors in the Meeting held on 27.05.2023",
            "news_id": "48667ea2-b42c-4e96-bb74-0a9a25b6ed3f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf011be9-abaa-40bb-bea6-c382f44236ec.pdf",
            "news_date": "2023-05-27 16:01:54",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2022",
            "news_body": "Unaudited financial results for the quarter and nine months ended 31.12.2022 along with limited review report",
            "news_id": "209bc13d-61fb-412e-8e31-709c4b0c4f82",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fc6f6f7-facc-4d9c-9bfd-3b2ee32505a3.pdf",
            "news_date": "2023-02-08 14:11:15",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On 11.11.2022",
            "news_body": "Outcome of the Meeting of Board of Directors held on 11.11.2022",
            "news_id": "21d328ac-e44d-4a47-a254-9f8a8d3623c7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33d80466-a52b-4f3c-a882-fc364889a23e.pdf",
            "news_date": "2022-11-11 13:44:01",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for .:- Regulation 30 Read With Reg. 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015                                         <BR> <BR>",
            "news_body": "We would like to inform you that the Board at its meeting held today approved the unaudited financial results for the quarter ended 30th June 2022. <BR> <BR> Please find attached the unaudited financial results for the quarter ended 30th June 2022 along with the limited review report obtained from the statutory auditor of the Company.<BR> <BR> The Audit Committee of the Company has been reconstituted to include Ms. Chitra Ravichandran, Independent Director as member of the Committee.   <BR> <BR>",
            "news_id": "8e0b226f-2915-4a80-a40e-7235c6833cfe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95cdb490-1be7-4110-bc43-5a66945830b6.pdf",
            "news_date": "2022-08-11 13:36:11",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 26Th May 2022",
            "news_body": "1. AUDITED FINANCIAL RESULTS<BR> <BR> Approval of audited financial results of the Company for the quarter and year ended 31st March 2022. <BR> <BR> Please find enclosed the following:<BR> <BR> 1.  Audited financial statements (standalone) for the quarter and year ended 31st March 2022 along with Auditor's report for the said period<BR> <BR> 2. Declaration on Unmodified Opinion in the Auditors' Report for Financial Year ended March 31, 2022<BR> <BR> <BR> 2. ANNUAL GENERAL MEETING<BR> <BR> The 27th Annual General Meeting of the members of the Company is scheduled to be held on Thursday, 28th July 2022 at 12:00 Noon through video conferencing and other audio visual means. <BR> <BR>  <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> 3. To open wholly owned subsidiary of Bafna Pharmaceuticals Limited in Australia.<BR>",
            "news_id": "a3a464cc-5e44-4228-be8e-31444c12d649",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46ae147a-22b7-443b-9a38-9aaf8addc519.pdf",
            "news_date": "2022-05-26 14:55:10",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result",
            "news_body": "We would like to inform you that the Board at its meeting held on today approved:<BR> <BR> 1. The un-audited financial results for the Third Quarter ending 31st December 2021. Please find attached the un-audited financial results for Third Quarter ending 31st December 2021 along with the Limited Review Report obtained from the statutory auditor of the Company",
            "news_id": "11961fa2-8a54-4a5c-8b13-f8e80bca5e5c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=caed8097-258e-4824-8233-612584a25241.pdf",
            "news_date": "2022-02-10 16:26:29",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result For The Half Year Ending 30Th Sep 2021",
            "news_body": "1. Approved the un - audited financial results of the Company for the quarter /half year ended September 30, 2021. Please find attached Limited Review Report from the Statutory Auditor.<BR> 2. Statutory Auditors comments along with Management's Reply:<BR>",
            "news_id": "6f11079d-a891-4382-a360-503cb9e9ef2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=228412b2-6d4a-44a8-bb08-bc5a2b939e35.pdf",
            "news_date": "2021-11-12 14:28:06",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations') as amended, this is to inform you that the Board of Directors ('Board') of the Company, had at its meeting held today i.e. Friday, November 12, 2021, the Board has decided the following matters:<BR> 1. Approved the un - audited financial results of the Company for the quarter /half year ended September 30, 2021. Please find attached Limited Review Report from the Statutory Auditor.<BR> 2. Statutory Auditors comments along with Management's Reply:<BR> 3. Raising of funds by way of offer and issue of equity shares to the existing shareholders of the Company on a rights basis (Rights Issue) for an aggregate amount upto INR 50 Crore.    <BR>",
            "news_id": "aa614d05-554a-411a-b2c6-d32e913f2dd1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f639df1-538d-4db5-a820-17e97225b043.pdf",
            "news_date": "2021-11-12 14:20:57",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Q1 2021-22 Results",
            "news_body": "The Board of Directors of the Company at their meeting held on today inter-alia transacted the following business.:-<BR> <BR> 1. UN-AUDITED FINANCIAL RESULT<BR> <BR> Approval of un-audited financial results of the Company for the quarter ending 30th June 2021. Please find attached  Limited Review Report from the statutory auditor of the Company M/s. R. Sathyanarayanan & Co.<BR> <BR>",
            "news_id": "02a14d57-5c30-4fb7-a9af-9db88d39b91e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fdc016e-3355-45bb-90e6-de1e4e06447d.pdf",
            "news_date": "2021-08-05 17:00:11",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 05Th August 2021",
            "news_body": "The Board of Directors of the Company at their meeting held on today inter-alia transacted the following business.:-<BR> <BR> 1. UN-AUDITED FINANCIAL RESULT   <BR> <BR> Approval of un-audited financial results of the Company for the quarter ending 30th June 2021. Please find attached  Limited Review Report from the statutory auditor of the Company M/s. R. Sathyanarayanan & Co.<BR>",
            "news_id": "a49e692b-d213-4195-926b-4b1e23d73bfe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=423c847c-9495-4ebb-980b-2bf7c49fa447.pdf",
            "news_date": "2021-08-05 14:03:53",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Discrepancies In Standalone Financial Results",
            "news_body": "We acknowledge the receipt of your email dated 17th July 2021 and our reply is as follow:<BR> <BR> Discrepancy: In PDF of Cash Flow Statement - Closing Balance of Cash & Cash Equivalent Not Tallying.(Confirm Net Increase/ [Decrease] In Cash or cash Equivalents Figure is Positive & Negative).Kindly File Rectified Figures of Cash Flow Statement.<BR> <BR> Company's Reply<BR> <BR> Revised Cash Flow Statement is attached herewith.<BR>",
            "news_id": "3011a27f-ef10-4542-a272-8e294825f2bc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a131913b-36cc-409c-86e7-873ec7a47558.pdf",
            "news_date": "2021-07-26 16:52:13",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Sub.:- Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Details Of Related Party Transactions<BR> <BR>",
            "news_body": "Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed herewith the disclosure of related party transactions for the half-year ended March 31, 2021.<BR> <BR> This is for your information and record.<BR>",
            "news_id": "97bb156a-4839-4197-b8d2-6d9039b655d5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaf5137d-f3f2-43e6-aab6-0f03af797cb9.pdf",
            "news_date": "2021-07-09 15:38:54",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result For The Year Ending 31.03.2021",
            "news_body": "1. AUDITED FINANCIAL RESULT<BR> <BR> Approval of audited financial results of the Company for the quarter and year ending 31st March 2021.  M/s. R. Sathyanarayanan & Co, Chartered Accountant, the Statutory Auditors of the Company have issued Audit Report with modified opinion along with Statement on impact of Modified opinion thereon.<BR> <BR> Please find enclosed 'Audited Financial Results, Audit Report, 'Statement of Assets & Liabilities' and Statement on Impact of Modified Opinion thereon for the year ended on March 31, 2021.<BR> <BR> 2. ANNUAL GENERAL MEETING<BR> <BR> The 26th Annual General Meeting of the members  of the Company  is scheduled  to be held on Saturday the 14th August 2021.<BR> <BR>",
            "news_id": "ad4d5a22-66e6-4d38-ab79-3fb5c23da717",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d639a7a-78a8-4f0b-a9a2-621ccdf74259.pdf",
            "news_date": "2021-06-25 15:35:48",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "1. AUDITED FINANCIAL RESULT<BR> <BR> Approval of audited financial results of the Company for the quarter and year ending 31st March 2021.  M/s. R. Sathyanarayanan & Co, Chartered Accountant, the Statutory Auditors of the Company have issued Audit Report with modified opinion along with Statement on impact of Modified opinion thereon.<BR> <BR> Please find enclosed 'Audited Financial Results, Audit Report, 'Statement of Assets & Liabilities' and Statement on Impact of Modified Opinion thereon for the year ended on March 31, 2021.<BR> <BR> 2. ANNUAL GENERAL MEETING<BR> <BR> The 26th Annual General Meeting of the members  of the Company  is scheduled  to be held on Saturday the 14th August 2021.<BR> <BR>",
            "news_id": "acbb9d6f-177a-4b5f-83d2-4f29fd692cf9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99705397-2625-41ff-b2ee-8cc2412443f7.pdf",
            "news_date": "2021-06-25 15:24:18",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On 12Th February 2021",
            "news_body": "We would like to inform you that the Board at its meeting held on today approved:<BR> <BR> 1. The un-audited financial results for the Third Quarter ending 31st December 2020. Please find attached the un-audited financial results for Third Quarter ending 31st December 2020 along with the Limited Review Report obtained from the statutory auditor of the Company<BR>",
            "news_id": "fe189fdb-4500-4e80-a7c5-b980cdbb432e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1d4d698-35f5-4dab-ac24-179a8d7e80e0.pdf",
            "news_date": "2021-02-12 14:45:41",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "We would like to inform you that the Board at its meeting held on today approved:<BR> <BR> 1. The un-audited financial results for the Third Quarter ending 31st December 2020. Please find attached the un-audited financial results for Third Quarter ending 31st December 2020 along with the Limited Review Report obtained from the statutory auditor of the Company.<BR> <BR>",
            "news_id": "f7c2c668-c27b-438a-9b8d-591986de21e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee743fdc-71e7-46df-bf47-7959c9a73860.pdf",
            "news_date": "2021-02-12 14:38:06",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}